Medical Transcription Billing (MTBC) Receiving Somewhat Positive Media Coverage, Study Finds

News articles about Medical Transcription Billing (NASDAQ:MTBC) have been trending somewhat positive recently, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Medical Transcription Billing earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 44.4319712859896 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

A number of brokerages have commented on MTBC. HC Wainwright reaffirmed a “buy” rating and issued a $5.00 price target on shares of Medical Transcription Billing in a research note on Thursday, March 8th. ValuEngine raised Medical Transcription Billing from a “sell” rating to a “hold” rating in a research note on Tuesday, February 20th. Finally, Zacks Investment Research cut Medical Transcription Billing from a “buy” rating to a “hold” rating in a research note on Saturday, January 6th.

How to Become a New Pot Stock Millionaire

Shares of Medical Transcription Billing (MTBC) traded up $0.07 during trading on Tuesday, reaching $3.80. The company’s stock had a trading volume of 249,368 shares, compared to its average volume of 514,736. The company has a quick ratio of 2.06, a current ratio of 2.06 and a debt-to-equity ratio of 0.01. The stock has a market cap of $43.04, a PE ratio of -5.32 and a beta of 1.61. Medical Transcription Billing has a 1-year low of $0.29 and a 1-year high of $5.44.

Medical Transcription Billing (NASDAQ:MTBC) last announced its quarterly earnings results on Wednesday, March 7th. The technology company reported $0.04 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.01) by $0.05. The business had revenue of $8.29 million for the quarter, compared to analysts’ expectations of $8.30 million. Medical Transcription Billing had a negative return on equity of 10.97% and a negative net margin of 17.50%. sell-side analysts forecast that Medical Transcription Billing will post -0.25 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Medical Transcription Billing (MTBC) Receiving Somewhat Positive Media Coverage, Study Finds” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit